Related Experiment Video
Updated: Jul 17, 2025

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
Outcomes Prediction in Complex High-Risk Indicated Percutaneous Coronary Interventions in the Older Patients
Alexander Marschall1, David Martí Sánchez1, José Luis Ferreiro2
1Department of Cardiology, Central Defense Hospital Gómez Ulla, Madrid, Spain; University of Alcalá, Madrid, Spain.
Insights
The Complex High-Risk Percutaneous Coronary Intervention (CHIP-PCI) score predicts in-hospital events in elderly patients but has limited 1-year predictive value. A modified score including additional factors significantly improves risk prediction.
Area of Science:
- Cardiology
- Geriatrics
- Interventional Cardiology
Background:
- Complex high-risk indicated percutaneous coronary intervention (CHIP-PCI) is not well-defined or validated in elderly populations.
- Risk stratification is crucial for managing percutaneous coronary intervention (PCI) in older adults.
Purpose of the Study:
- To evaluate the predictive accuracy of the CHIP-PCI score in patients aged 75 years and older.
- To identify additional risk factors for major adverse cardiac and cerebrovascular events (MACCEs) in this demographic.
- To develop an improved risk prediction model for elderly patients undergoing PCI.
Main Methods:
- Pooled analysis of 2,725 patients (≥75 years) from three registries (2012-2019).
- Evaluation of the original CHIP-PCI score variables and identification of additional predictors for 1-year and in-hospital MACCEs.
- Comparison of the discriminatory performance of the original and a modified CHIP-PCI score using area under the curve (AUC).
Main Results:
- The original CHIP-PCI score showed predictive value for in-hospital MACCEs (AUC 0.657) but limited value for 1-year MACCEs (AUC 0.598).
- Independent predictors for 1-year MACCEs included previous myocardial infarction, low ejection fraction, chronic kidney disease, left main PCI, and nonradial access.
- Diabetes mellitus, anemia, and severe calcification were also significant predictors.
- The modified CHIP-PCI score (including 5 patient-related and 3 procedure-related factors) significantly improved discrimination for both in-hospital (AUC 0.729) and 1-year MACCEs (AUC 0.647).
Conclusions:
- The CHIP-PCI score maintains prognostic value for in-hospital MACCEs in elderly patients.
- The original CHIP-PCI score has limited predictive value for 1-year MACCEs in this population.
- A modified CHIP-PCI score incorporating additional patient and procedural factors significantly enhances risk prediction accuracy for elderly patients undergoing PCI.
Abstract:
Complex high-risk indicated percutaneous coronary intervention (CHIP-PCI) is a poorly defined concept, which has not been validated in an older population before. This study aimed to evaluate the predictive value of the CHIP-PCI score in a large cohort of elderly patients and to identify potential further risk factors. This is a pooled analysis of 3 registries that included patients aged ≥75 years who underwent percutaneous coronary intervention from 2012 to 2019: the multicenter prospective EPIC05-Sierra 75 study, the multicenter retrospective PACO-PCI (EPIC-15) registry, and the single-center, prospective Elderly-HCD registry. A total of 2,725 patients with a mean age of 81 ± 4 years were included in the study; 269 patients (10%) met the primary end point of 1-year major adverse cardiac and cerebrovascular events (MACCEs), and 51 patients (2%) had in-hospital MACCEs. Of the 12 investigated original CHIP-PCI score variables, 5 were independent predictors: previous myocardial infarction, left ventricular ejection fraction <30%, chronic kidney disease, left main coronary artery percutaneous coronary intervention, and nonradial access. Furthermore, diabetes mellitus, anemia, and severe calcification showed to be significant predictors of MACCEs. The additional variables improved the discriminatory value of the CHIP-PCI score for 1-year MACCEs (modified CHIP-PCI score: area under the curve [AUC] 0.647 vs original CHIP-PCI score: AUC 0.598, p = 0.02) and in-hospital MACCEs (AUC 0.729 vs 0.657, p = 0.003, respectively). In conclusion, the CHIP-PCI score retains its prognostic value in older patients for in-hospital MACCEs; however, it is of limited value at 1-year follow-up. The modified CHIP-PCI score, including the 5 patient-related and 3 procedure-related factors, significantly improved its discriminatory potential.
More Related Videos
10:03Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome III: Diagnostic Studies
Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease V: Postoperative Nursing Management
Peripheral Artery Disease IV: Nursing Management
Acute Coronary Syndrome IV: Interprofessional Care